Immune-related biomarkers predict the prognosis and immune response of breast cancer based on bioinformatic analysis and machine learning-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune-related biomarkers predict the prognosis and immune response of breast cancer based on bioinformatic analysis and machine learning

Published:2023-06-08 Issue:3 Volume:23 Page:
ISSN:1438-793X
Container-title:Functional & Integrative Genomics
language:en
Short-container-title:Funct Integr Genomics

Author:

Zheng Xuewei,Ma Haodi,Dong Yirui,Fang Mengmiao,Wang Junxiang,Xiong Xin,Liang Jing,Han Meng,You Aimin,Yin Qinan,Huang Wenbin

Funder

Fundamental Research Funds for Henan University of Science and Technology

A-type Doctoral Talent Project of Henan University of Science and Technology

Publisher

Springer Science and Business Media LLC

Subject

Genetics,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10142-023-01124-x.pdf

Reference46 articles.

1. Bates JP, Derakhshandeh R, Jones L, Webb TJ (2018) Mechanisms of immune evasion in breast cancer. BMC Cancer 18:556. https://doi.org/10.1186/s12885-018-4441-3

2. Chan CY, Chiu DK, Yuen VW, Law CT, Wong BP, Thu KL, Cescon DW, Soria-Bretones I, Cheu JW, Lee D, Tse AP, Zhang MS, Tan KV, Ng IO, Khong PL, Yau TC, Bray MR, Mak TW, Wong CC (2022) CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proc Natl Acad Sci USA 119:e2119514119. https://doi.org/10.1073/pnas.2119514119

3. Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, Androsiglio M, Ward T, Olsen E, Niknafs YS, Merajver S, Thomas DG, Brown PH, Lawrence TS, Nyati S, Pierce LJ, Chinnaiyan A, Speers C (2020) TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. J Clin Invest 130:958–973. https://doi.org/10.1172/JCI130435

4. Chen K, Xing J, Yu W, Xia Y, Zhang Y, Cheng F, Rao T (2021) Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays. Front Oncol 11:782981. https://doi.org/10.3389/fonc.2021.782981

5. Darvin P, Toor SM, Sasidharan Nair V, Elkord E (2018) Immune checkpoint inhibitors: recent progress and potential biomarkers. Exp Mol Med 50:1–11. https://doi.org/10.1038/s12276-018-0191-1

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High Glycolytic Activity Signature Reveals CCNB2 as a Key Therapeutic Target in Triple-Negative Breast Cancer;Frontiers in Bioscience-Landmark;2024-08-23

2. Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning;Biochemical Genetics;2024-02-21

3. PLAU and GREM1 are prognostic biomarkers for predicting immune response in lung adenocarcinoma;Medicine;2024-02-02

4. The integration of multidisciplinary approaches revealed PTGES3 as a novel drug target for breast cancer treatment;Journal of Translational Medicine;2024-01-20

5. Role of UBE2C in Brain Cancer Invasion and Dissemination;International Journal of Molecular Sciences;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3